Glenmark Pharmaceuticals launches Tevimbra, a new lung cancer treatment drug, in India. This marks Glenmark's entry into ...

Lung cancer is a big problem. It claims many lives each year. Around 160,000 people die annually in the US. This figure is ...

Lung carcinomas are the most common metastatic tumor donors. However, the opposite phenomenon (lung carcinoma as a recipient of metastasis from prostate adenocarcinoma) is rarely previously reported ...

Vaping might be safer than cigarette smoking, but they carry their own health risks. A New Jersey man’s electronic cigarette ...

The non-small cell lung cancer market grow at a CAGR of around 9.3% from 2021-2031. PORTLAND, OR, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, ...

Despite a robust cash position, Revolution Medicines' high burn rate and lofty valuation increase risk and sensitivity to ...

As with all cancers, lung cancer has a preferred path when it spreads. Knowing where it tends to go can help you pick up on symptoms and let your health team know, so they can intervene early.

During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell ...

A paper published by researchers at Fox Chase Cancer Center highlights the case of a patient who was diagnosed with adenoid ...